CHIRAG PATEL: Open Payments
NPI 1790741312 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 54 payments from 10 companies in 2025. Trend: 2023 $896 · 2024 $1,131 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $204 |
| Madrigal Pharmaceuticals | 8 | $185 |
| Ipsen Biopharmaceuticals, Inc | 7 | $164 |
| ABBVIE INC. | 9 | $136 |
| Gilead Sciences, Inc. | 6 | $112 |
| ORPHALAN INC | 3 | $64 |
| Novo Nordisk Inc | 2 | $48 |
| Echosens North America, Inc. | 3 | $47 |
| Intra-Sana Laboratories | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: XIFAXAN, REZDIFFRA, IQIRVO, MAVYRET, CUVRIOR, Wegovy, Fibroscan, RELTONE 200 MG.
Industry payments across TN — which companies pay providers there.
